7-year Follow-Up Outcomes after Stereotactic Ablation Radiotherapy for Stage I NSCLC: Results of a Phase Π Clinical Trial

BACKGROUND: We evaluated the efficacy, pattern of failure, and toxicity of stereotactic ablative radiotherapy (SABR) for medically inoperable clinical stage I non-small cell lung cancer (NSCLC) in a prospective clinical trial with 7 years follow-up. METHODS: Eligible patients with histologically con...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer
Huvudupphovsmän: Sun, Bing, Brooks, Eric D., Komaki, Ritsuko, Liao, Zhongxing, Jeter, Melenda, McAleer, Mary, Allen, Pamela K., Balter, Peter A., Welsh, James D., O’Reilly, Michael, Gomez, Daniel, Hahn, Stephen. M., Roth, Jack A., Mehran, Reza J., Heymach, John V., Chang, Joe Y.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5544582/
https://ncbi.nlm.nih.gov/pubmed/28346656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30693
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk